CN104055189A - Application of sucrose invert sugar in functional beverage - Google Patents
Application of sucrose invert sugar in functional beverage Download PDFInfo
- Publication number
- CN104055189A CN104055189A CN201410095007.6A CN201410095007A CN104055189A CN 104055189 A CN104055189 A CN 104055189A CN 201410095007 A CN201410095007 A CN 201410095007A CN 104055189 A CN104055189 A CN 104055189A
- Authority
- CN
- China
- Prior art keywords
- group
- sugar
- drinks
- sucrose
- sucrose inversion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229930006000 Sucrose Natural products 0.000 title claims abstract description 114
- 239000005720 sucrose Substances 0.000 title claims abstract description 114
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 title claims abstract description 107
- 235000020510 functional beverage Nutrition 0.000 title abstract description 12
- 229960004903 invert sugar Drugs 0.000 title abstract description 7
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000013361 beverage Nutrition 0.000 claims abstract description 35
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 30
- 230000006870 function Effects 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 22
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 claims abstract description 21
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 claims abstract description 21
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960001948 caffeine Drugs 0.000 claims abstract description 18
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229960003080 taurine Drugs 0.000 claims abstract description 15
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 13
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000004472 Lysine Substances 0.000 claims abstract description 12
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229960000367 inositol Drugs 0.000 claims abstract description 11
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 11
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 11
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims abstract description 5
- 235000020733 paullinia cupana extract Nutrition 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 4
- 229960003646 lysine Drugs 0.000 claims abstract description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract 3
- 235000000346 sugar Nutrition 0.000 claims description 127
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 16
- 235000008151 pyridoxamine Nutrition 0.000 claims description 14
- 239000011699 pyridoxamine Substances 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 11
- 235000003599 food sweetener Nutrition 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 239000003765 sweetening agent Substances 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 239000004376 Sucralose Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 10
- 229960003966 nicotinamide Drugs 0.000 claims description 10
- 235000005152 nicotinamide Nutrition 0.000 claims description 10
- 239000011570 nicotinamide Substances 0.000 claims description 10
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical group O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 10
- 235000019408 sucralose Nutrition 0.000 claims description 10
- AHRFRRASJMTTQU-UHFFFAOYSA-N 6-methyl-2,2-dioxooxathiazin-4-one;potassium Chemical compound [K].CC1=CC(=O)NS(=O)(=O)O1 AHRFRRASJMTTQU-UHFFFAOYSA-N 0.000 claims description 9
- 108010011485 Aspartame Proteins 0.000 claims description 9
- 239000000605 aspartame Substances 0.000 claims description 9
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 9
- 235000010357 aspartame Nutrition 0.000 claims description 9
- 229960003438 aspartame Drugs 0.000 claims description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- 239000005715 Fructose Substances 0.000 claims description 8
- 229930091371 Fructose Natural products 0.000 claims description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 3
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 claims description 3
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 claims description 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 235000018977 lysine Nutrition 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019160 vitamin B3 Nutrition 0.000 abstract 1
- 239000011708 vitamin B3 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 description 25
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- 229960003495 thiamine Drugs 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 235000010374 vitamin B1 Nutrition 0.000 description 12
- 239000011691 vitamin B1 Substances 0.000 description 12
- 229930003451 Vitamin B1 Natural products 0.000 description 11
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 11
- 235000014633 carbohydrates Nutrition 0.000 description 10
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 10
- 230000002641 glycemic effect Effects 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 150000003722 vitamin derivatives Chemical class 0.000 description 7
- 240000003444 Paullinia cupana Species 0.000 description 6
- 235000000556 Paullinia cupana Nutrition 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 235000013336 milk Nutrition 0.000 description 6
- 239000008267 milk Substances 0.000 description 6
- 210000004080 milk Anatomy 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 235000021152 breakfast Nutrition 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 125000000185 sucrose group Chemical group 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- -1 l-cn Chemical compound 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 4
- 239000004299 sodium benzoate Substances 0.000 description 4
- 235000010234 sodium benzoate Nutrition 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 150000003445 sucroses Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 102000040350 B family Human genes 0.000 description 3
- 108091072128 B family Proteins 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 2
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 2
- 235000009685 Crataegus X maligna Nutrition 0.000 description 2
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 2
- 235000009486 Crataegus bullatus Nutrition 0.000 description 2
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 2
- 235000009682 Crataegus limnophila Nutrition 0.000 description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 description 2
- 240000000171 Crataegus monogyna Species 0.000 description 2
- 235000002313 Crataegus paludosa Nutrition 0.000 description 2
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000012730 carminic acid Nutrition 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OVBPIULPVIDEAO-GFCCVEGCSA-N (2r)-2-[[4-[(2-amino-4-oxo-1h-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-GFCCVEGCSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010058679 Skin oedema Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003923 mental ability Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to an application of sucrose invert sugar in a functional beverage. The sucrose-invert sugar, as an efficacy-promoting agent of functional components in the functional beverage, is added to the functional beverage for promoting functions of the functional components to work. Concentration of the sucrose invert sugar in the functional beverage is 50-300 g/L. The sucrose invert sugar is a mixture composed of isomaltulose and trehalulose, wherein a mass ratio of the isomaltulose to the trehalulose is 1-99.99%/99-0.01%. The functional components in the functional beverage is at least one selected from taurine, inositol, nicotinamide, vitamin B12, vitamin B6, lysine, caffeine, vitamin PP and a guarana extract. The invention is advantaged in that the functional components in the functional beverage is effectively promoted to work and performances of the functional beverage are improved so that the beverage can more effectively replenish energy and alleviate fatigue and is low in cost.
Description
Technical field
The present invention relates to the application of sucrose inversion sugar in functional beverage, specifically, sucrose inversion sugar is as the efficacy exertion of functional components in function promoter promotion functions beverage, to improve the performance of functional beverage.
Background technology
Drinks and functional food are in the market various, are mainly used in makeup energy, fatigue-relieving, replenishing vitamins etc.For example:
1) composition of red drink heavily material comprises taurine, lysine, and pyridoxamine, cobalamin, nicotinic acid, inositol and caffeine, white granulated sugar.
2) composition of pulsation vitamin drinking comprises pure water, white granulated sugar, cider, flavoring essence, citric acid, vitamin C, vinegar, niacinamide (vitamin B3), pantothenic acid (vitamin B5), pyridoxamine, cobalamin.
3) Qi Li is the new drinks of releasing, and functional component is: taurine, vitamin B1, pyridoxamine, l-cn, inositol, caffeine, niacinamide etc.Sugar source is sucrose and glucose.
4) High Tier Brand force health-care, contains above-mentioned similar functional component equally.Sugar source is similarly sucrose.
5) " a kind of keep fit, body-building health-care beverage " who proposes in patent CN101238891B.Functional component is wherein hawthorn, matrimony vine and Huajuhong; The sugared source of using is sucrose and honey.The fruit of Chinese wolfberry contains abundant carrotene, retinol1, B1, B2, C etc.Hawthorn is containing carrotene, vitamin A, thiamine, riboflavin, niacin, vitamin C, vitamin E.
All there are the following problems for above-mentioned functions beverage: use sucrose, glucose, fructose or other starch sugar as carbohydrate sugar source, energy is provided.Above-mentioned carbohydrate can absorb by fast decoupled in vivo, and blood sugar raises rapidly, declines rapidly afterwards.Conventionally within 30 minutes after taking, just reach glycemic peaks, more just fall back at the end after 30 minutes, and to reverse extension.On the other hand, the functional component in these beverages effective acting time is in vivo conventionally all more than 4 hours.Therefore, the too short glycemic peaks time can not make the functional component in beverage play one's part to the full.Unfavorable for the effect of makeup energy, fatigue-relieving like this.The 6th) in example, take embedding mode to carry out slowly-releasing carbohydrate, there is uncertainty.
Summary of the invention
The object of the invention is to solve the problem that in prior art, in functional beverage, functional components can not play one's part to the full, provide a kind of by sucrose inversion sugar for improving the method for drinks performance.More effectively makeup energy and fatigue-relieving, realize low cost simultaneously and reach target.
To achieve these goals, technical scheme of the present invention is as follows:
The application of sucrose inversion sugar in drinks, it is characterized in that, described sucrose inversion sugar is added in drinks, effect promoter as functional components in drinks, the Function of promotion functions composition, the concentration of described sucrose inversion sugar in drinks is 50g/L-300g/L, and described sucrose inversion sugar is the mixture of isomaltoketose and trehalulose, and the mass ratio of described isomaltoketose and trehalulose is 1-99.99%/99-0.01%.
Preferably, the functional components in described drinks is to be selected from least one of taurine, inositol, niacinamide, cobalamin, pyridoxamine, lysine, caffeine, vitamin C, pantothenic acid, nicotinic acid, Guarana extract.
Preferably, in described every liter of beverage, the content of taurine is that the content of 100-600mg, caffeine is that the content of 20-400mg, lysine is 40-400mg.
Preferably, the content of described every liter of beverage mysoinositol is 60-120mg.
Preferably, in described every liter of beverage, the content of niacinamide is 8-80mg.
Preferably, in described every liter of beverage, the content of cobalamin is that the content of 0.6-1.8 μ g, pyridoxamine is 0.4-1.6mg.
Preferably, in described drinks, also comprise high sweetener and/or essence and/or pigment and/or anticorrisive agent.
Preferably, described high sweetener comprises at least one that is selected from Sucralose, Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt, hesperidine dihydrochalcone and protein sugar.
Preferably, in described drinks, also comprise starch sugar, described starch sugar comprises sucrose, glucose, fructose or oligoisomaltose.
First we introduce sucrose inversion sugar.Chinese patent 00109673.7 and Chinese patent CN102071235 B provide and have used enzyme preparation the sucrose solution of 50% left and right concentration to be converted into the method for the sucrose inversion liquid that contains isomaltoketose and trehalulose.Above-mentioned conversion fluid is reached to the mother liquor producing after more than 95% isomaltoketose crystalline powder and crystallization by crystallization and the dry purity that obtains.In above-mentioned conversion fluid, contain 70-85%(butt) isomaltoketose, 13-29.5%(butt) trehalulose, 2%(butt) following assorted sugar.Above-mentioned crystallization and dried isomaltoketose crystalline powder contain trehalulose and the assorted sugar of 0.5-5% conventionally, and we are referred to as to transform Icing Sugar.In above-mentioned mother liquor, contain 35-60%(butt) isomaltoketose, 35-60%(butt) trehalulose, the assorted sugar below 6%.In this mother liquor, the total content of isomaltoketose and trehalulose is more than 94%.In above-mentioned assorted sugar, contain sucrose, glucose, fructose and melezitose etc.
We are by above-mentioned: 1) sucrose inversion liquid; 2) invert sugar crystal powder; 3) mother liquor obtaining after crystallization, the unified sucrose inversion sugar that is referred to as.When application, can be used alone, but also also mix together.Especially recommend directly to use the mother liquor obtaining after sucrose inversion liquid or crystallization.Compare and use invert sugar crystal powder, directly use conversion fluid or mother liquor can significantly reduce cost of material.
In this sucrose inversion sugar, the total content of isomaltoketose and trehalulose is more than 94%.All the other are assorted sugar.In assorted sugar, can comprise: sucrose, glucose, fructose and melezitose etc.We are the functional sugar composition in sucrose inversion sugar using isomaltoketose and trehalulose.
Isomaltoketose and trehalulose are isomers.We are referred to as sucrose inversion sugar, and they have a common characteristic: the digestion rate in human body is slow, but the heat producing is identical with sucrose.Conventionally, the glycemic peaks time after edible sucrose or glucose is at 30 minutes, then declines rapidly; And after 30 minutes from eating glycemic peaks time after edible isomaltoketose and trehalulose continues up to 180 minutes.This sucrose inversion sugar has the characteristic that glycemic peaks is steady, energy mild and discharge for a long time, also can be described as energy slow-release.For obese patient, energy discharges slowly, is conducive to fat-reducing.In addition, the feature that this sucrose inversion sugar is not utilized by oral bacteria in addition.There is the feature that regulates mouthfeel, covers bad flavor simultaneously, add in food and drink and can improve mouthfeel.
In order to improve the performance of drinks, we are applied to the feature of this sucrose inversion sugar and characteristic the drinks of makeup energy, fatigue-relieving, and the functional component in beverage is better played a role.The method solving is, sucrose or other carbohydrate carbohydrate with above-mentioned sucrose inversion sugar in completely alternative or part alternative functions beverage, improve the performance of beverage.
On the one hand, utilize sucrose inversion sugar to extend the glycemic peaks time, energy service time is significantly extended; On the other hand, glycemic peaks promotes the functional component in beverage better to play a role for a long time.Make an addition to functional component in beverage effective acting time in vivo conventionally all more than 4 hours, the glycemic peaks of short time can not make functional component well be utilized.The present invention, by adding sucrose inversion sugar, when extending the glycemic peaks time, promotes that following several functions composition is better utilized.
1, taurine: have and accelerate glycometabolic function, namely accelerate the glycolysis of glucose in blood, be used for accelerating to provide energy.But if the glycolysis of sugared source is complete in body, taurine will lose and accelerate glycometabolic function so.Therefore, need to maintain for a long time blood sugar steady, energy could be continuously provided.Taurine in this case competence exertion better acts on.It is steady for a long time that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar, thereby taurine is better played a role.
2, pyridoxamine: belong to a kind of of B family vitamin, be phosphorylated in vivo coenzyme form, participate in enzyme metabolism, the sugared source in carbohydate metabolism in catalysis muscle and liver transforms; Contribute to the energy conversion process in brain and other tissue.In liver, sugared source is limited, need to supplement in time; Sugared source in muscle particularly, approach exhaustion soon in strenuous exercise, therefore must supplement.If can not get supplementing, cause on the contrary the symptoms such as muscle turns sour, brain fag.Therefore blood sugar need to be maintained steady, the effect of competence exertion pyridoxamine.It is steady that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar, thereby pyridoxamine is better played a role.
3, caffeine: directly act on nervous centralis, impel thinking to become quick clear; Can reduce tired; Can promote metabolism; Can stimulate liver to discharge glycogen source to increase energy i (in vivo); Impel adrenaline in blood obviously to increase, thereby accelerate heart rate, increase CBF, improve oxygen conveying capacity, impel tricarboxylic acid cycle smooth, guarantee that energy is constantly supplemented.Need constantly to supplement glycogen and blood sugar.It is steady for a long time that interpolation sucrose inversion sugar can maintain blood sugar, thereby caffeine is better played a role.
4, nicotinic acid is also referred to as B3 and niacinamide: belong to a kind of of B family vitamin, participate in the oxidizing process of energetic supersession, tissue respiration and the process that decompose in sugared source; Participate in the synthetic of protein, fat and DNA.These functions need blood sugar concentration stably equally.It is steady for a long time that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar concentration, thereby niacinamide is better played a role.
5, cobalamin: belong to a kind of of B family vitamin, be converted in vivo the metabolism that various coenzyme participate in carbohydrate, fat and protein; Promote erythrocytic formation; Safeguard neural normal function.B12 has the function for carbohydate metabolism.It is steady for a long time that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar concentration, thereby cobalamin is better played a role.
6, vitamin B1: be human energy metabolism, particularly glycometabolism is necessary, old friend's body is conventionally relevant with the heat of picked-up to the requirement of thiamines.When the energy of human body is mainly derived from carbohydrate, the requirement of vitamin B1 is maximum.Vitamin B1 plays a part crucial in carbohydrate metabolism, so its requirement is generally taken the photograph people's amount according to carbohydrate and decided, and while approximately supplying with every 1000 kilocalories of heat energy, needs approximately 0.5 milligram of vitamin B1.Vitamin B1 has by the thermal release in sugar out, is then decomposed into the effect of water and carbon dioxide.If be therefore deficient in vitamin B1 when decomposing, just cannot decompose final stage, and leave in vivo the materials such as lactic acid and pyrimidine acid.Once in body, the content of lactic acid increases, and just can make people tired, makes people occur numbness in hands and feet, skin edema, even affects cerebral nerve.Vitamin B1 is once not in body, somebody can become very anxiety or failure of memory, and especially easily uneasy and irritability even also can be disputed with people.So first replenishing vitamins B1 refreshes oneself better.Conversely, if when blood sugar is not enough, the effect of vitamin B1 also reduces.It is steady for a long time that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar concentration, thereby vitamin B1 is better played a role.
7, Guarana, has another name called brazilian cocoa.Be than the coffee thing of coffee also, energy food, eliminates tiredly, is this maximum plant of caffeine in the world.Guarana is a kind of wild certain kind of berries of Ma Yaxun area special product, includes natural caffeine, vitamin, unsaponifiable matter and tannin, and abundant alkaloid, tannic acid, protein etc.Can help to resist fatigue, increase adrenergic release, stimulate fat combustion, therefore there is the effect of fat-reducing.The main characteristics of guarana is: the natural caffeine that it is contained, can excite nerve gradually and lentamente, and stimulate the term of validity maintaining long, and stimulation is gentleer, human body is safe from harm, and the product in other sources is conventionally rapid-action, but the duration is short.Effect is similar with caffeine, and effect continues slowly.Therefore more need continuous sugared source to support.It is steady for a long time that the sucrose inversion sugar that interpolation the present invention proposes can maintain blood sugar concentration, thereby Guarana is better played a role.
8, lysine: aspect antifatigue, lysine and blood sugar have complementation.In addition, add the mouthfeel that sucrose inversion sugar can improve lysine.
9, inositol: the metabolism that inositol can balance fat and sugar.Add sucrose inversion thing and can extend the time of inositol balanced action.
When using sucrose inversion sugar to substitute or part substitutes sucrose or other carbohydrate sugar source, need to consider sugariness.The sugariness of sucrose inversion sugar is generally 40-50% of sucrose.Can make up sugariness by adding high sweetener.The use of high sweetener can be used standard (GB2760-2013) to select according to food additives: Sucralose, Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt, hesperidine dihydrochalcone and protein sugar etc.Also can add their mixture.
According to mouthfeel and appearance requirement, can use standard (GB2760-2013) to add in right amount different types of essence and pigment to improve mouthfeel and outward appearance according to food additives.Also anticorrisive agent can be added as requested in right amount, as Sodium Benzoate, potassium sorbate etc.
beneficial effect
Compared with prior art, advantage of the present invention is as follows: the effectively performance of the effect of functional components in promotion functions beverage, improved the performance of drinks, and more effectively makeup energy and fatigue-relieving, and cost is low.
accompanying drawing explanation
Fig. 1 is the variation tendency of 21 groups of students ' reading speed;
Fig. 2 is the variation tendency of 21 groups of student's error rates;
Fig. 3 is the variation tendency of 21 groups of student's mental working ability indexes.
The specific embodiment
For making that architectural feature of the present invention and the effect reached are had a better understanding and awareness, in order to preferred embodiment and accompanying drawing, coordinate detailed explanation.
Aforementioned functional component has application more in drinks.Carry out by the following examples the interaction between the sugared sources such as more different functional components and sucrose inversion sugar, sucrose.For illustrative purposes only, claim is not limited to this to following examples.Beverage embodiment can be made into electuary form or aqua form.
Embodiment mono-adds sucrose inversion sugar in the beverage that contains taurine and caffeine
In 1000ml beverage, add respectively following composition:
The preferred 500mg of taurine 100-600mg
The preferred 100mg of inositol 60-120mg
The preferred 40mg of niacinamide 8-80mg
Cobalamin 0.6-1.8 μ g is 1.2 μ g preferably
The preferred 1.2mg of pyridoxamine 0.4-1.6mg
The preferred 200mg of lysine 40-400mg
The preferred 150mg of caffeine 20-400mg
The preferred 200g of sucrose inversion sugar 50-300g
Citric acid 0.5-3g
Essence 0.1-0.5g
The preferred 0.02g of lemon yellow 0.01-0.1g
The preferred 0.02g of carmine 0.01-0.05g
The preferred 0.002g of Sodium Benzoate 0.001-1g
In described drink formula, all the components all calculates with butt.Take sucrose inversion sugar as functional sugar source.In the present embodiment, in sucrose inversion sugar, the content ratio of isomaltoketose and trehalulose is 1-99.99%/99-0.01%.In actual applications, also can add in addition the starch sugars such as sucrose, glucose and fructose and mix use with sucrose inversion sugar respectively.Conventionally, the addition of sucrose inversion sugar is more many more can play a role.In every 1000 milliliters of drinks, the addition of sucrose inversion sugar should be no less than 50 grams (butts), just can play the effect of mutually promoting with other functional component.Till can adding at most and not producing precipitation.General every 1000 milliliters can be added at most 300 grams of (butt) sucrose inversion sugar.The sugariness of sucrose inversion sugar is the 40-50% of sucrose.Can use high sweetener suitably to regulate sugariness.
In drink formula, add high sweetener Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt or Sucralose, addition is: the addition of Aspartame or 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt is below 2% of sugared source total amount (butt); If selection Sucralose, addition is below 0.8% of sugared source total amount (butt), or below 2.5% of beverage total amount.
Citric acid in drink formula, essence, lemon yellow, Sodium Benzoate are submember, do not participate in the process of Power supply and fatigue-relieving.Taurine, inositol, niacinamide, cobalamin, pyridoxamine, lysine and caffeine are functional components, participate in Power supply and the fatigue-relieving process of human body.Sucrose inversion sugar, as Power supply composition, participates in Power supply and the fatigue-relieving process of human body.In the present embodiment, acting on of functional component has narration above.It is in order fully to promote to improve mental and physical labourer's ability to work and the effect of fatigue-relieving that their cooperation is added.The addition of functional component can not be as the criterion with scope listed in table 1 very little conventionally, the requirement that can not exceed national standard simultaneously.
For the effect of checking sucrose inversion sugar, using respectively sucrose, sucrose inversion sugar is sweetener as sugared source and Sucralose, take the optimization formula of embodiment mono-as basis, is mixed with beverage; Meanwhile, using each functional component, is sugared source with sucrose, sucrose inversion sugar respectively, makes the beverage of a plurality of formulas, formula as the actual addition/scope of table 1().The concrete composition of the sucrose inversion sugar using in table 1 is as follows: isomaltoketose 78.5%, trehalulose 20.6%, all the other are assorted sugar.
the list of table 1 formulaevery 1000 milliliters of beverages add
With 21 drink formulas in table 1, compare test.Subjects is student enrollment, is divided into 21 groups, every group of 30 people.First 20 minutes of 21 groups of students in class, everyone drinks respectively each 350 milliliters of 21 kinds of beverages in table 1.In table 1, n group is blank group; K group is control sucrose group; I group is sucrose inversion sugar control group.Amount to four class, respectively cephalomere 10 minutes before the class and within 10 minutes, carry out testing experiment after complete four class.
Experiment content adopts An Feimofu wordchecking table to measure Experiment on Function.Metering Experiment on Function can provide the objective data relevant to learning fatigue.Require experimenter in limiting time, to complete the operation of appointment.Wherein, the workload completing in the unit interval is operating rate index, reaction cortex excited process; Error rate is correctness index, reaction cortex process of intercentral inhibition; During learning fatigue, there is obstacle in brain cortical, and operating rate slows down, and error rate increases.In before the class, measure respectively Experiment on Function test 1min, second timing after class.After end, investigator's statistics should be deleted number, mistake is deleted and counted, always reads number of words, and reads the calculating of word speed and error rate.Mental working ability index=(readding number of words/2) * [(should delete number-mistake and delete number)/should delete number]
Statistical method: use SPSS21.0 statistical software by dosage operation trials result input database, and data are carried out to the trend analysis of the variance analysis of Repeated Measurement Data and the mean of detection index.Below will to student's mental activity and ability to work variation, analyze according to statistics.
, each index statistics
Respectively cephalomere before the class and on after complete four class, adopt An Feimofu wordchecking table to 21 groups, 630 student enrollment measure Experiment on Function.Individual/60s), error rate (unit: %) and mental working ability index then according to gained metering operation trials result, calculate the reading rate that z group, y group, a group, b group, c group, d group, e group, f group, g group, h group, i group, j group, k group, l group, m group, n group, o group, p group, q group, r group and x organize these 21 groups of students (unit:.
table 2 is 21 groups of students' reading rate, error rate and mental working ability index situation before class
| Group | Reading rate | Error rate | Mental working ability index |
| Z group | 430.72±128.93 | 0.23±0.22 | 373.50±117.16 |
| Y group | 431.31±122.33 | 0.24±0.21 | 377.10±113.16 |
| A group | 432.54±124.61 | 0.23±0.25 | 377.82±116.69 |
| B group | 431.84±123.78 | 0.23±0.31 | 378.06±114.07 |
| C group | 432.39±125.20 | 0.23±0.29 | 377.47±115.88 |
| D group | 432.87±126.08 | 0.24±0.21 | 378.12±115.94 |
| E group | 433.30±122.64 | 0.25±0.27 | 377.20±120.34 |
| F group | 432.95±127.43 | 0.24±0.26 | 378.09±116.09 |
| G group | 433.09±126.15 | 0.24±0.18 | 377.67±118.52 |
| H group | 433.12±121.37 | 0.23±0.22 | 377.29±109.94 |
| I group | 432.96±125.12 | 0.24±0.26 | 377.34±113.82 |
| J group | 433.33±124.45 | 0.25±0.27 | 377.49±115.87 |
| K group | 432.15±124.87 | 0.23±0.31 | 377.45±117.87 |
| L group | 431.59±122.68 | 0.24±0.21 | 378.05±115.68 |
| M group | 431.94±123.59 | 0.25±0.27 | 377.69±116.59 |
| N group | 432.66±124.11 | 0.24±0.18 | 377.54±117.11 |
| O group | 432.57±125.09 | 0.23±0.22 | 378.23±118.09 |
| P group | 432.38±123.68 | 0.24±0.26 | 378.41±116.68 |
| Q group | 431.86±124.95 | 0.23±0.25 | 378.11±117.95 |
| R group | 431.79±124.63 | 0.25±0.27 | 377.94±117.63 |
| X group | 433.50±118.15 | 0.24±0.23 | 378.21±111.32 |
21 groups of students' reading rate, error rate and mental working ability index situation after class on table 3
| Group | Reading rate | Error rate | Mental working ability index |
| Z group | 455.46±122.88 | 0.36±0.26 | 360.63±106.51 |
| Y group | 464.25±123.12 | 0.31±0.24 | 376.53±104.55 |
| A group | 468.37±120.55 | 0.28±0.31 | 382.87±103.17 |
| B group | 470.15±125.24 | 0.28±0.24 | 383.21±107.12 |
| C group | 475.91±121.31 | 0.28±0.27 | 383.21±103.16 |
| D group | 472.38±118.79 | 0.24±0.28 | 385.49±102.11 |
| E group | 478.52±121.28 | 0.25±0.26 | 379.62±101.14 |
| F group | 474.34±123.44 | 0.23±0.29 | 380.49±103.06 |
| G group | 476.33±120.77 | 0.26±0.21 | 384.27±103.05 |
| H group | 480.22±126.66 | 0.27±0.23 | 385.83±108.98 |
| I group | 474.58±120.75 | 0.26±0.18 | 382.29±104.06 |
| J group | 476.16±124.92 | 0.26±0.25 | 381.93±102.98 |
| K group | 453.26±125.87 | 0.39±0.23 | 354.84±105.87 |
| L group | 452.88±123.68 | 0.40±0.23 | 355.67±103.68 |
| M group | 485.67±124.59 | 0.22±0.24 | 389.48±104.59 |
| N group | 451.98±125.11 | 0.38±0.25 | 355.81±105.11 |
| O group | 484.96±126.09 | 0.23±0.24 | 390.24±106.09 |
| P group | 486.51±124.68 | 0.22±0.24 | 388.94±104.68 |
| Q group | 485.37±125.95 | 0.21±0.23 | 389.23±105.95 |
| R group | 486.12±125.63 | 0.22±0.24 | 390.15±105.63 |
| X group | 482.41±119.05 | 0.23±0.19 | 387.21±101.23 |
2, the statistical analysis of each index
In this test, testing time point is divided into: cephalomere before the class with upper complete four class after; Fractions tested is: z group, y group, a group, b group, c group, d group, e group, f group, g group, h group, i group, j group, k group, l group, m group, n group, o group, p group, q group, r group and x group; Test index is divided into: reading rate, error rate and mental working ability index.Use SPSS21.0 statistical software will measure operation trials result input database, and data information is carried out to the variance analysis of duplicate measurements and the trend of test index average is analyzed.
the before class statistical analysis of student's test index
Take reading rate during as processing factor, Mauchly ' s Test of Sphericity check obtains Mauchly ' s=0.928, probability P value=0.451, this result shows spherical symmetric, group F value=1.329 so, probability P value=0.264, shows that the difference of reading rate between 21 groups does not exist significant statistical significance, and 21 groups of students' reading rate is similar; Take error rate during as processing factor, Mauchly ' s=0.944, probability P value=0.296, this result shows spherical symmetric, group F value=0.122 so, probability P value=0.873, there is not significant statistical significance in the difference that shows error rate between 21 groups, 21 groups of students' error rate is similar; Take mental working ability index during as processing factor, Mauchly ' s=0.915, probability P value=0.017, this result shows spherical asymmetric, select so group F value=1.602 after correction, probability P value=0.227, shows that the difference of mental working ability index between 21 groups does not exist significant statistical significance, and 21 groups of students' mental working ability index is similar.
the statistical analysis of student's test index after attending class
Take reading rate during as processing factor, Mauchly ' s Test of Sphericity check obtains Mauchly ' s=0.966, probability P value=0.325, this result shows spherical symmetric, group F value=6.489 so, probability P value=0.000, the difference that shows reading rate between 21 groups has significant statistical significance, and p group >r group >m group >q group >o group >x group >h group >e group >g group >j group >c group >i group >f group >d group >b group >a group >y group >z group >k group >l group >n group, take error rate during as processing factor, Mauchly ' s=0.954, probability P value=0.401, this result shows spherical symmetric, group F value=5.163 so, probability P value=0.002, the difference that shows error rate between 21 groups has significant statistical significance, and q group <m group=p group=r group <f group=o group=x group <d group <e group <g group=i group=j group <h group <a group=b group=c group <y group <z group <n group <k group <l group, take mental working ability index during as processing factor, Mauchly ' s=0.959, probability P value=0.388, this result shows spherical symmetric, group F value=5.370 so, probability P value=0.000, the difference that shows mental working ability index between 21 groups has significant statistical significance, and o group >r group >m group >q group >p group >x group >h group >d group >g group >b group=c group >a group >i group >j group >f group >e group >y group >z group >n group >l group >k group.
21 groups of students' reading rate, error rate and the variance analysis of mental working ability index after class on table 4
Variance analysis from table 4, by z group, a group, b group, c group, d group, e group, f group, g group, h group, j group, l group, m group, o group, p group, q group, r group, the reading rate of x group and y group, error rate, the test result of mental working ability index and k group are analyzed, the probability P value of each between-group variance analysis result is all less than 0.01, because significance is 0.05, so we can think z group, a group, b group, c group, d group, e group, f group, g group, h group, j group, l group, m group, o group, p group, q group, r group, x group and y group are in reading rate, error rate, on mental working ability index, there is significant difference with k group (control sucrose group).
21 groups of students' reading rate, error rate and mental working ability index variance analysis (Continued) after class on table 5
Variance analysis from table 5, by y group, a group, b group, c group, d group, e group, f group, g group, h group, j group, z group, l group, m group, o group, p group, q group, the reading rate of r group and x group, error rate, the test result of mental working ability index and n group are analyzed, the probability P value of each between-group variance analysis result is all less than 0.01 or 0.05, because significance is 0.05, so we can think y group, a group, b group, c group, d group, e group, f group, g group, h group, j group, z group, l group, m group, o group, p group, q group, r group and x group are in reading rate, error rate, on mental working ability index, there is significant difference with n group (blank group).
21 groups of students' reading rate, error rate and mental working ability index variance analysis (Continued) after class on table 6
Variance analysis from table 6, by y group, a group, b group, c group, d group, e group, f group, g group, h group, j group, z group, l group, m group, o group, p group, q group, the reading rate of r group and x group, error rate, the test result of mental working ability index and i group are analyzed, the probability P value of each between-group variance analysis result is all less than 0.01 or 0.05, because significance is 0.05, so we can think y group, a group, b group, c group, d group, e group, f group, g group, h group, j group, z group, l group, m group, o group, p group, q group, r group and x group are in reading rate, error rate, on mental working ability index, there is significant difference with i group (sucrose inversion sugar control group).
3. conclusion draws the following conclusions by above data analysis class
3.1in sucrose inversion sugar his-and-hers watches 1 formula, listed functional component has facilitation.Each listed functional component with sucrose inversion sugar compatibility under performance be obviously better than the performance with sucrose compatibility.
Sucrose inversion sugar has energy slow-release and promotes energy slow-release effect.In the middle of the group that contains sucrose inversion sugar in all quoting, test result is obviously better than the group that contains sucrose.Illustrate that student's energy of drinking containing sucrose inversion sugar group is sufficient.
Embodiment bis-adds sucrose inversion sugar take vitamin in main drinks
In the every 1000ml product of nutritional labeling, contain:
The preferred 150g of sucrose inversion sugar 50-300g
The preferred 300mg of vitamin C 250-500mg
The preferred 30mg of niacinamide (vitamin B3) 8-80mg
The preferred 3mg of pantothenic acid (vitamin B5) 2-4mg
The preferred 1mg of pyridoxamine 0.4-1.6mg
The preferred 1.2mg of cobalamin 0.6-1.8 μ g
Citric acid 0.5-3g
Vinegar 0.4-4g
Fruit juice 20-40g flavoring essence 0.2-1.5mg
Pure water surplus
The sugared source of the present embodiment is sucrose inversion sugar.Isomaltoketose in sucrose inversion sugar and the mass ratio of trehalulose are 1-99.99%/99-0.01%.Can use separately as required sucrose inversion sugar, also can not mix use with the starch sugar such as sucrose, glucose and fructose by sucrose inversion sugar.Sugar adds high sweetener Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt or Sucralose in source, and addition is: the addition of Aspartame or 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt is below 2% of sugared source total amount; If selection Sucralose, addition is below 0.8% of sugared source total amount.
Embodiment tri-adds sucrose inversion sugar in Guarana beverage
In 1000ml beverage, add respectively following composition:
The preferred 100mg of inositol 60-120mg
The preferred 40mg of nicotinic acid 8-80mg
Cobalamin 0.6-1.8 μ g is 1.2 μ g preferably
The preferred 1.2mg of pyridoxamine 0.4-1.6mg
The preferred 200mg of lysine 40-400mg
The preferred 300mg of Guarana extract 200-400mg
The preferred 200g of sucrose inversion sugar 50-300g
Citric acid 0.5-3g is appropriate
Essence 0.1-0.5g is appropriate
The preferred 0.02g of lemon yellow 0.01-0.1g
The preferred 0.02g of carmine 0.01-0.05g
The preferred 0.002g of Sodium Benzoate 0.001-0.02g
In the present embodiment, the isomaltoketose in sucrose inversion sugar and the mass ratio of trehalulose are 1-99.99%/99-0.01%.Can use separately as required sucrose inversion sugar, also can not mix use with the starch sugar such as sucrose, glucose and fructose by sucrose inversion sugar.Sugar adds high sweetener Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt or Sucralose in source, and addition is: the addition of Aspartame or 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt is below 2% of sugared source total amount; If selection Sucralose, addition is below 0.8% of sugared source total amount.
Major function composition in the middle of Guarana extract is caffeine.Therefore, Guarana beverage is actual is the beverage that contains caffeine.
Embodiment tetra-adds sucrose inversion sugar in breakfast milk
In the present embodiment, the feature promotion energy slow-release feature of sucrose inversion sugar and promotion functions composition being played a role is additional in the middle of the formula of breakfast milk food.Make breakfast milk when energy is provided, there is the energy slow-release of promotion effect.
Specific implementation method is as follows:
The first step: the whole milk powder that is 10-20% by percentage, the sucrose inversion of 13-15% sugar, 5% yeast extract, 0.05% salt, 0.25% monoglyceride and 0.2% CMC(sodium carboxymethylcellulose) mix in proportion, add the water of 76 ℃ of 60.6-72.5% to make its dissolving;
Second step: by mixed liquor at 50-60 ℃, homogeneous under 20-25MPa;
The 3rd step: packed in bottle into sealed cans, sterilization after homogeneous.
In sucrose inversion sugar in the present embodiment and milk powder, the lactose of 3-5% has formed the carbohydrate in breakfast food.Can continuously provide the human body required sugared source of requiring mental skill the morning to maintain blood sugar and within considerable time, keep higher level.Abundant calcium, phosphorus, unsaturated fatty acid ester and cellulose of solubleness is provided in milk powder.Yeast extract provides the nutritional labelings such as nucleotides, new subsides, selenium, retinol (vitamin A), thiamine (vitamin B1), riboflavin (vitamin B2), folic acid (vitamin(e) M, Folie Acid).
In the present embodiment, in sucrose inversion sugar, the mass ratio of isomaltoketose and trehalulose is 1-99.99%/99-0.01%.
Embodiment five adds sucrose inversion sugar in nutrient breakfast beverage
In 1000ml beverage, add respectively following composition:
Protein 10.0g
Fat 12 g
Sucrose inversion sugar 160g
Sodium 1g
Niacinamide 14mg
Phosphorus 250mg
Potassium 520mg
Calcium 300mg
Zinc 5.4mg
Taurine 150mg
Juice content >=5%
Milk level >=30%
In the present embodiment, the isomaltoketose in sucrose inversion sugar and the mass ratio of trehalulose are 1-99.99%/99-0.01%.
Claims (10)
1. the application of sucrose inversion sugar in drinks, it is characterized in that, described sucrose inversion sugar is added in drinks, effect promoter as functional components in drinks, the Function of promotion functions composition, the concentration of described sucrose inversion sugar in drinks is 50g/L-300g/L, and described sucrose inversion sugar is the mixture of isomaltoketose and trehalulose, and the mass ratio of described isomaltoketose and trehalulose is 1-99.99%/99-0.01%.
2. the application of sucrose inversion sugar according to claim 1 in drinks; it is characterized in that, the functional components in described drinks is to be selected from least one of taurine, inositol, niacinamide, cobalamin, pyridoxamine, lysine, caffeine, vitamin C, pantothenic acid, nicotinic acid, Guarana extract.
3. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, in described every liter of beverage, the content of taurine is that the content of 100-600mg, caffeine is 20-400mg.
4. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, in described every liter of beverage, the content of lysine is 40-400mg.
5. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, the content of described every liter of beverage mysoinositol is 60-120mg.
6. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, in described every liter of beverage, the content of niacinamide is 8-80mg.
7. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, in described every liter of beverage, the content of cobalamin is that the content of 0.6-1.8 μ g, pyridoxamine is 0.4-1.6mg.
8. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, also comprises high sweetener and/or essence and/or pigment and/or anticorrisive agent in described drinks.
9. the application of sucrose inversion sugar according to claim 7 in drinks, is characterized in that, described high sweetener comprises at least one that is selected from Sucralose, Aspartame, 3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide potassium salt, hesperidine dihydrochalcone and protein sugar.
10. the application of sucrose inversion sugar according to claim 1 in drinks, is characterized in that, in described drinks, also comprises starch sugar, and described starch sugar comprises sucrose, glucose, fructose or oligoisomaltose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410095007.6A CN104055189A (en) | 2014-03-14 | 2014-03-14 | Application of sucrose invert sugar in functional beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410095007.6A CN104055189A (en) | 2014-03-14 | 2014-03-14 | Application of sucrose invert sugar in functional beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104055189A true CN104055189A (en) | 2014-09-24 |
Family
ID=51543347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410095007.6A Pending CN104055189A (en) | 2014-03-14 | 2014-03-14 | Application of sucrose invert sugar in functional beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104055189A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107535769A (en) * | 2016-06-23 | 2018-01-05 | 黄然 | A kind of energy drink for contributing to body-building and effect of weight reducing |
| CN108685000A (en) * | 2018-05-22 | 2018-10-23 | 天马（安徽）国药科技股份有限公司 | A kind of drinks that duration relieves fatigue |
| CN108777991A (en) * | 2015-11-12 | 2018-11-09 | 派迪瓦私人有限公司 | Including low-calorie, low-glycemic（GI）And the food and beverage product of the sugar composite of continuous energy release |
| CN108887535A (en) * | 2018-06-20 | 2018-11-27 | 天马（安徽）国药科技股份有限公司 | A kind of health beverages and preparation method thereof that restoring consciouness is allayed excitement |
| CN109691606A (en) * | 2017-11-24 | 2019-04-30 | 上海冬泽特医食品有限公司 | A kind of beverage taken when the production for puerpera |
| CN110692878A (en) * | 2019-10-11 | 2020-01-17 | 山东赛珥医药科技有限公司 | Health-care and nutritional functional beverage |
| WO2020237340A1 (en) * | 2019-05-31 | 2020-12-03 | Rischbieter Ivo | High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same |
| US20210353705A1 (en) * | 2018-10-04 | 2021-11-18 | India Globalization Capital, Inc. | Method and composition for relieving fatigue and restoring energy |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1436472A (en) * | 2002-02-08 | 2003-08-20 | 新三井制糖株式会社 | Preparation of soya-bean milk or soya-bean milk beverage |
| CN1997283A (en) * | 2004-07-21 | 2007-07-11 | 曼海姆/奥克森富特旭德楚克股份公司 | Improved mixtures containing cocoa |
| EP1393637B1 (en) * | 2001-05-14 | 2007-11-14 | Mitsui Sugar Co., Ltd. | Use of palatinose for sustaining mental concentration and attentiveness |
| CN101151036A (en) * | 2005-03-29 | 2008-03-26 | 三井制糖株式会社 | Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| US20100330234A1 (en) * | 2008-01-31 | 2010-12-30 | Kowalczyk Joerg | Process for the production of fermented beverages |
| CN102448332A (en) * | 2009-04-15 | 2012-05-09 | 甜糖（曼海姆/奥克森富特）股份公司 | Trehalulose-containing composition, its preparation and use |
| CN103068259A (en) * | 2010-07-14 | 2013-04-24 | 甜糖（曼海姆/奥克森富特）股份公司 | Isomaltulose for use in enhancing mental performance |
-
2014
- 2014-03-14 CN CN201410095007.6A patent/CN104055189A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1393637B1 (en) * | 2001-05-14 | 2007-11-14 | Mitsui Sugar Co., Ltd. | Use of palatinose for sustaining mental concentration and attentiveness |
| CN1436472A (en) * | 2002-02-08 | 2003-08-20 | 新三井制糖株式会社 | Preparation of soya-bean milk or soya-bean milk beverage |
| CN1997283A (en) * | 2004-07-21 | 2007-07-11 | 曼海姆/奥克森富特旭德楚克股份公司 | Improved mixtures containing cocoa |
| CN101151036A (en) * | 2005-03-29 | 2008-03-26 | 三井制糖株式会社 | Sucrase activity inhibitor, glucoamylase activity inhibitor and food and feed containing the same |
| US20100330234A1 (en) * | 2008-01-31 | 2010-12-30 | Kowalczyk Joerg | Process for the production of fermented beverages |
| CN102448332A (en) * | 2009-04-15 | 2012-05-09 | 甜糖（曼海姆/奥克森富特）股份公司 | Trehalulose-containing composition, its preparation and use |
| CN103068259A (en) * | 2010-07-14 | 2013-04-24 | 甜糖（曼海姆/奥克森富特）股份公司 | Isomaltulose for use in enhancing mental performance |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108777991A (en) * | 2015-11-12 | 2018-11-09 | 派迪瓦私人有限公司 | Including low-calorie, low-glycemic（GI）And the food and beverage product of the sugar composite of continuous energy release |
| CN107535769A (en) * | 2016-06-23 | 2018-01-05 | 黄然 | A kind of energy drink for contributing to body-building and effect of weight reducing |
| CN109691606A (en) * | 2017-11-24 | 2019-04-30 | 上海冬泽特医食品有限公司 | A kind of beverage taken when the production for puerpera |
| CN108685000A (en) * | 2018-05-22 | 2018-10-23 | 天马（安徽）国药科技股份有限公司 | A kind of drinks that duration relieves fatigue |
| CN108887535A (en) * | 2018-06-20 | 2018-11-27 | 天马（安徽）国药科技股份有限公司 | A kind of health beverages and preparation method thereof that restoring consciouness is allayed excitement |
| US20210353705A1 (en) * | 2018-10-04 | 2021-11-18 | India Globalization Capital, Inc. | Method and composition for relieving fatigue and restoring energy |
| WO2020237340A1 (en) * | 2019-05-31 | 2020-12-03 | Rischbieter Ivo | High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same |
| CN110692878A (en) * | 2019-10-11 | 2020-01-17 | 山东赛珥医药科技有限公司 | Health-care and nutritional functional beverage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104055189A (en) | Application of sucrose invert sugar in functional beverage | |
| CN103211259B (en) | Anti-fatigue vitamin health care beverage and preparation method thereof | |
| CN105533213A (en) | Vitamin and mineral nutritional paste and preparation method thereof | |
| AU2014292651B2 (en) | Anti-fatigue composition and use thereof | |
| Burtscher et al. | The prolonged intake of L-arginine-L-aspartate reduces blood lactate accumulation and oxygen consumption during submaximal exercise | |
| CN106360179A (en) | Electrolyte sports beverage and preparation process thereof | |
| CN112137095A (en) | Sports nutritional composition and preparation method thereof | |
| CN108013299A (en) | Supplement physical efficiency beverage | |
| US20160129025A1 (en) | Anti-fatigue composition and use thereof | |
| CN101562994A (en) | Use of isomaltulose in food products having a regenerative effect | |
| CN101869141B (en) | Salty yoghourt capable of strengthening Fe, Zn and Ca and processing method thereof | |
| Singh et al. | EFFICACY OF PRE EXERCISE CARBOHYDRATE DRINK (GATORADE) ON THE RECOVERY HEART RATE, BLOOD LACTATE AND GLUCOSE LEVELS IN SHORT TERM INTENSIVE EXERCISE. | |
| CN103126026B (en) | Beverage for relieving effect of alcohol and preparation method thereof | |
| CN105146666B (en) | A kind of solid beverage for supplementing B family vitamin and preparation method thereof | |
| CN104017715A (en) | Passion fruit vinegar and preparation method thereof | |
| CN101124995A (en) | Refreshing consciousness nutritive beverage and food | |
| CN106490614A (en) | A kind of composition and its application as diabetes full nutrition formula food | |
| Sekartini et al. | The effect of lactose–isomaltulose-containing growing-up milks on cognitive performance of Indonesian children: a cross-over study | |
| Rizal et al. | The effect of watermelon beverage ingestion on fatigue index in young-male, recreational football players | |
| Zart et al. | Effects of commercial isotonic sports drinks during intermittent exertion | |
| EP2915433A1 (en) | A nutritional product composition for energy | |
| Holford et al. | The Stress Cure: How to resolve stress, build resilience and boost your energy | |
| EP2915432A1 (en) | A Nutritional Product composition for the Heart | |
| CN101245308A (en) | Vinegar rich in vitamin B and producing method thereof | |
| US8974832B1 (en) | Nutritional product composition for increasing human growth hormone and nitric oxide production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information |
Address after: Shanghai City, Putuo District No. 3370 North 200063 Applicant after: Shanghai Jianyuan Carbohydrate Co., Ltd. Address before: Shanghai City, Putuo District No. 3370 North 200063 Applicant before: Shanghai Jian Yuan carbohydrate Co., Ltd |
|
| COR | Change of bibliographic data | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140924 |
|
| WD01 | Invention patent application deemed withdrawn after publication |